Connect with us

Business

Deckers Brands stock sinks 15% after soft outlook raises concerns about Hoka, Ugg growth

Published

on

Deckers Brands stock sinks 15% after soft outlook raises concerns about Hoka, Ugg growth


Hoka shoes are seen in a store in Krakow, Poland on February 1, 2023. 

Jakub Porzycki | Nurphoto | Getty Images

Shares of footwear maker Deckers Brands plunged 15% Friday after the company trimmed its sales guidance for Hoka and Ugg — the two brands driving its growth — over concerns that tariffs are leading to a slide in demand.

Hoka, an up-and-coming running shoe brand, is now expected to grow by a low-teens percentage in fiscal 2026 after growing 24% in the year-ago period, while Boots brand Ugg is expected to grow in the range of a low to mid single-digit percentage, after growing 13% in the year-ago period.

In May, the company said Hoka and Ugg were expected to grow in the mid-teens and mid-single digits, respectively, in fiscal 2026 but it caveated that forecast by saying it was conceived prior to the introduction of President Donald Trump’s tariffs. At the time, it quantified the expected impact to its costs but said it remained to be determined what kind of impact the new duties could have on demand.

When reporting fiscal second-quarter earnings on Thursday, finance chief Steven Fasching said the impacts tariffs and higher prices are having on demand are now more clear.

“Part of the framework that we gave at the beginning of the year really said if tariffs did not have an impact on consumers, how we saw kind of certain growth, and we still believe that, right? But we do know and we are more currently seeing some impacts on the U.S. consumer,” Fasching told analysts on the company’s conference call. “So as U.S. consumers are beginning to see some price increases. It is impacting their purchase behavior within the consumer discretionary space.”

He added the guidance isn’t far off from what the company originally thought but acknowledged there is a “little bit of a reduction” in its forecast.

The slower pace of growth for Deckers’ two top-performing lines, along with the trim to their sales guidance, signals the two brands could be losing momentum after years of outperformance. Together, Hoka and Ugg account for the vast majority of Deckers’ revenue and have been critical in offsetting weaknesses in other categories.

CEO Dave Powers, however, downplayed fears of a long-term slowdown, telling investors that both brands remain strong among core consumers.

“We’re confident in the long-term trajectory of our portfolio,” Powers said. “While tariffs and inflation are creating near-term pressure, Hoka and Ugg continue to lead in brand heat and market share gains across their categories.”

Beyond Hoka and Ugg, Deckers’ full-year revenue guidance came in lower than analysts’ expectations. In fiscal 2026, the company expects revenue of about $5.35 billion, shy of Wall Street’s $5.45 billion forecast, according to LSEG. It expects earnings per share to be between $6.30 and $6.39, roughly in line with the $6.32 per share estimate, according to LSEG.

In the company’s call with analysts, Fasching warned that tariff costs could total about $150 million this fiscal year. Executives said they expect to offset roughly half of those costs through price adjustments and cost-sharing with factory partners.

Deckers’ shares have dropped more than 55% year to date, leaving investors on edge about any signs of decelerating demand.



Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals

Published

on

Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals


Novo Nordisk is looking for deals more than ever before, the CEO of the Danish drugmaker said in an interview with CNBC on Wednesday.

“If our ambition is to help hundreds of millions of patients out there, then we need not just the best, but the broadest pipeline in the world,” said Novo Nordisk CEO Mike Doustdar. “So let’s go and see who else basically has assets that are complementary to what we have. And we are quite active with those [business development] talks and acquisitions, and you’ll see more of those as well going forward.”

Novo created the market for GLP-1 weight loss drugs with its weekly shots Ozempic and Wegovy. More recently, the company has faced concerns from analysts about whether Novo’s pipeline is robust enough for it to remain a leader in the increasingly competitive obesity drug space.

Mike Doustdar, chief executive officer of Novo Nordisk A/S, during an interview in New York, US, on Wednesday, Feb. 11, 2026.

Michael Nagle | Bloomberg | Getty Images

Rival Eli Lilly has already overtaken Novo in market share for weekly GLP-1 shots, though Novo has taken an early lead in the new category of GLP-1 pills for weight loss.

Doustdar said he disagrees with the concerns about Novo’s upcoming treatments, arguing the drugmaker has “one of the best pipelines in the industry.” He pointed to Novo’s CagriSema, a drug candidate that targets GLP-1 and amylin, that Novo hopes will be approved at the end of this year, and an experimental amylin-targeting drug called zenagamtide that Novo has accelerated development of, among other assets.

“Of course, there’s a lot of things in my pipeline that right now I have the privy to look into and get excited (about) but not have shared it yet with the world,” he said. “So I am incredibly excited about our pipeline, and I would just say to the investors who are a little bit skeptical, wait and see.”

Doustdar spoke to CNBC after the company said its Wegovy pill performed better than expected in the first quarter, and it raised its full-year profit guidance.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.



Source link

Continue Reading

Business

Up to 150 former WHSmith high street stores to close

Published

on

Up to 150 former WHSmith high street stores to close



The stores were purchased by Modella Capital last year, and then rebranded under the name TGJones.



Source link

Continue Reading

Business

US stock markets today (May 6, 2026): Wall Street rallies to record highs, crude oil tumbles on Strait of Hormuz reopening hopes – The Times of India

Published

on

US stock markets today (May 6, 2026): Wall Street rallies to record highs, crude oil tumbles on Strait of Hormuz reopening hopes – The Times of India


US stock markets surged on Wednesday while oil prices plunged sharply as investors bet on a possible breakthrough in US-Iran negotiations that could reopen the Strait of Hormuz and restore global crude supplies, AP reported.The S&P 500 climbed 0.8 per cent and headed towards another record close. The Dow Jones Industrial Average rose 487 points, or 1 per cent, while the Nasdaq Composite gained 0.8 per cent.Brent crude, the international oil benchmark, slumped 5.7 per cent to $103.61 per barrel after falling from levels above $115 earlier this week. At one point during the session, Brent briefly dropped below $97 before recovering some losses.The rally came after US President Donald Trump said the Strait of Hormuz could be “OPEN TO ALL” if Iran accepts a reported agreement, though he did not disclose details of the proposed deal.The Strait of Hormuz has remained at the centre of the global energy crisis since the Iran conflict disrupted oil tanker movement through the Persian Gulf, pushing crude prices sharply higher and stoking inflation fears worldwide.Markets also drew optimism from Trump’s indication that the US may scale back efforts to reopen the strait through military means, while China called for a comprehensive ceasefire after talks between Chinese and Iranian foreign ministers.Asian and European markets also rallied strongly. South Korea’s Kospi surged 6.5 per cent to cross the 7,000 mark for the first time, while Hong Kong’s Hang Seng rose 1.2 per cent. London’s FTSE 100 gained 2.2 per cent and France’s CAC 40 climbed 2.9 per cent.On Wall Street, technology and AI-linked stocks led gains after strong earnings reports.AMD jumped 19.3 per cent after reporting better-than-expected quarterly profit and revenue. CEO Lisa Su said continued growth in artificial intelligence demand had boosted the company’s performance.The chipmaker also projected revenue growth of around 46 per cent in the current quarter.Super Micro Computer rallied 14.2 per cent after posting earnings above analyst estimates.CVS Health gained 8.2 per cent after beating first-quarter expectations and raising its full-year forecasts.Stocks of companies with high fuel costs also rose sharply amid hopes of lower oil prices. United Airlines climbed 5.2 per cent, while Carnival and Royal Caribbean gained 5.5 per cent and 5.2 per cent, respectively.In the bond market, Treasury yields fell as easing oil prices reduced inflation concerns. The yield on the 10-year Treasury dropped to 4.35 per cent from 4.43 per cent a day earlier.Lower bond yields generally reduce borrowing costs for households and businesses and tend to support equity valuations.



Source link

Continue Reading

Trending